Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 6
2018 20
2019 17
2020 12
2021 9
2022 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Fluoroquinolone-associated suicide.
Kommalapati A, Wallam S, Tella SH, Qureshi ZP, Bennett CL. Kommalapati A, et al. Eur J Intern Med. 2018 Sep;55:e21-e22. doi: 10.1016/j.ejim.2018.07.012. Epub 2018 Jul 18. Eur J Intern Med. 2018. PMID: 30031596 No abstract available.
Molecular-Targeted Therapies in Hepatocellular Carcinoma.
Mahipal A, Kommalapati A, Mehta R, Kim RD. Mahipal A, et al. Among authors: kommalapati a. 2019 Aug 6. In: Hoshida Y, editor. Hepatocellular Carcinoma: Translational Precision Medicine Approaches [Internet]. Cham (CH): Humana Press; 2019. Chapter 11. 2019 Aug 6. In: Hoshida Y, editor. Hepatocellular Carcinoma: Translational Precision Medicine Approaches [Internet]. Cham (CH): Humana Press; 2019. Chapter 11. PMID: 32078262 Free Books & Documents. Review.
Prevention and treatment of FGFR inhibitor-associated toxicities.
Mahipal A, Tella SH, Kommalapati A, Yu J, Kim R. Mahipal A, et al. Among authors: kommalapati a. Crit Rev Oncol Hematol. 2020 Nov;155:103091. doi: 10.1016/j.critrevonc.2020.103091. Epub 2020 Sep 1. Crit Rev Oncol Hematol. 2020. PMID: 32961472 Review.
Novel targeted treatment options for advanced cholangiocarcinoma.
Mahipal A, Kommalapati A, Tella SH, Lim A, Kim R. Mahipal A, et al. Among authors: kommalapati a. Expert Opin Investig Drugs. 2018 Sep;27(9):709-720. doi: 10.1080/13543784.2018.1512581. Epub 2018 Aug 30. Expert Opin Investig Drugs. 2018. PMID: 30124336 Review.
Second-line therapies in advanced biliary tract cancers.
Tella SH, Kommalapati A, Borad MJ, Mahipal A. Tella SH, et al. Among authors: kommalapati a. Lancet Oncol. 2020 Jan;21(1):e29-e41. doi: 10.1016/S1470-2045(19)30733-8. Lancet Oncol. 2020. PMID: 31908303 Review.
61 results